The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/37442
StudyName: Eligibility Stage III, IVa, or IVb Squamous Cell Carcinoma of the Larynx, With ECOG Performance Status 0-2 NCT02207439
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 26.07.2019
License: Creative Commons BY 4.0

----

Description: 
A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma Larynx; ODM derived from: https://clinicaltrials.gov/show/NCT02207439
